SCL
Stepan Company
$44.13
+$1.48(+3.47%)
59
Overall
100
Value
18
Tech
--
Quality
Market Cap
$1.10B
Volume
161.38K
52W Range
$41.82 - $79.11
Target Price
$85.00
Company Overview
| Mkt Cap | $1.10B | Price | $44.13 |
| Volume | 161.38K | Change | +3.47% |
| P/E Ratio | 21.8 | Open | $43.06 |
| Revenue | $2.2B | Prev Close | $42.65 |
| Net Income | $50.4M | 52W Range | $41.82 - $79.11 |
| Div Yield | 1.58% | Target | $85.00 |
| Overall | 59 | Value | 100 |
| Quality | -- | Technical | 18 |
No chart data available
Latest News
Satellos Bioscience Unveils Groundbreaking Research in Duchenne Muscular Dystrophy Treatment
TipRanks Canadian Auto-Generated Newsdesk•5 days ago
Satellos Bioscience Strengthens Leadership and Advances Clinical Trials for DMD Treatment
TipRanks Canadian Auto-Generated Newsdesk•9 days ago
Kaveri Seed Releases Q2 FY’26 Earnings Call Transcript
TipRanks India Auto-Generated Newsdesk•10 days ago
Scancell’s iSCIB1+ Shows Promising Results in Melanoma Treatment
TipRanks UK Auto-Generated Newsdesk•17 days ago
Scilex Enters Exclusive License Agreement with Datavault AI
TipRanks Auto-Generated Newsdesk•19 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SCL | $44.13 | +3.5% | 161.38K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |